• Western blot analysis of various lysates using PNMA2 Rabbit polyclonal antibody (STJ116242) at 1:3000 dilution. _Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. _Lysates/proteins: 25 Mu g per lane. _Blocking buffer: 3% nonfat dry milk in TBST. _Detection: ECL Enhanced Kit. _Exposure time: 90s.

Anti-PNMA2 antibody (1-140) (STJ116242)

SKU:
STJ116242

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-PNMA2 (1-140) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: PNMA2
Gene ID: 10687
Uniprot ID: PNMA2_HUMAN
Immunogen Region: 1-140
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 1-140 of human PNMA2 (NP_009188.1).
Immunogen Sequence: MALALLEDWCRIMSVDEQKS LMVTGIPADFEEAEIQEVLQ ETLKSLGRYRLLGKIFRKQE NANAVLLELLEDTDVSAIPS EVQGKGGVWKVIFKTPNQDT EFLERLNLFLEKEGQTVSGM FRALGQEGVSPATVPCISPE
Tissue Specificity Brain-specific. In some cancer patients, specifically expressed by testicular tumor cells.
Protein Name Paraneoplastic Antigen Ma2
40 Kda Neuronal Protein
Onconeuronal Antigen Ma2
Paraneoplastic Neuronal Antigen Mm2
Cellular Localisation Nucleus
Nucleolus
Alternative Antibody Names Anti-Paraneoplastic Antigen Ma2 antibody
Anti-40 Kda Neuronal Protein antibody
Anti-Onconeuronal Antigen Ma2 antibody
Anti-Paraneoplastic Neuronal Antigen Mm2 antibody
Anti-PNMA2 antibody
Anti-KIAA0883 antibody
Anti-MA2 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance